NSAIDで悪化した呼吸器疾患におけるオミクス:上下気道からの現在の証拠
Aleksandr iAkushev1, Piotr Szatkowski2, Maria Vorobeva1
1Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Allergy
|September 5, 2025
まとめ
非ステロイド性抗炎症薬による呼吸器疾患 (N-ERD) は上部と下部の両方を含む. N-ERDの分子メカニズムを理解し,新しい治療法を見つけるには,統合されたマルチオミックスの研究が必要です.
科学分野:
- * 呼吸器医学
- * 免疫学
- * 分子生物学
背景:
- * 非ステロイド抗炎症薬による呼吸器疾患 (N-ERD) は,上部と下部の両方に影響を及ぼす複雑な炎症状態です.
- * 現在の研究では,呼吸器を別々に分析することが多く,N-ERDの病原性に関する理解は不完全である.
- N-ERDの効果的な管理には,呼吸道部位間の分子相似性と違いを明らかにすることが不可欠です.
研究 の 目的:
- * N- ERD上下呼吸道における既存のオミクス研究 (トランスクリプトミクス,プロテオミクス,メタボロミクス,エピジェノミクス) を検討する.
- * 現在のN-ERDオミクス研究における知識のギャップと課題を特定する.
- * N-ERDの包括的な理解のために,統合されたマルチオミックスのアプローチを提唱する.
主な方法:
- * N-ERDにおけるオミクス研究に関する包括的な文献検索.
- * トランスクリプトミア,プロテオミア,メタボロミア,エピジェノミア分析からの発見の合成.
- * 研究設計,方法論,データの比較性を批判的に評価する.
主要な成果:
- * オミックスの研究は,N- ERDに関する最初の分子洞察を提供した.
- * 直接的な比較を制限する多種多様性がある.
- * 異なるが重複する分子メカニズムは,異なる呼吸道区画で動作する可能性があります.
結論:
- * 統合されたマルチオミクス分析は,N-ERDのシステムレベルの理解に不可欠です.
- * 研究の相互比較を容易にするため,標準化された研究枠組みが必要である.
- * 堅固なバイオマーカーとN-ERDの標的治療は,総合的な呼吸道アプローチを必要とします.
さらに関連する動画
14:48Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
5.2K
12:27The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
Published on: April 2, 2014
16.8K
関連する概念動画
01:17Drugs Used in Lower Respiratory Disorders: Overview
573
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
573
01:16Drugs Used in Upper Respiratory Disorders: Overview
356
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
356
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.0K
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:20COPD: Pathogenesis and Clinical Features
512
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
512
01:20Asthma: Pathogenesis and Management
573
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
573